Controlled release systems of angiogenic growth factors for cardiovascular diseases

Author： Esaki Jiro   Marui Akira   Tabata Yasuhiko   Komeda Masashi  

Publisher： Informa Healthcare

ISSN： 1742-5247

Source： Expert Opinion on Drug Delivery, Vol.4, Iss.6, 2007-11, pp. : 635-649

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Controlled release of heparin-binding growth factors using heparin-containing particulate systems for tissue regeneration

By Joung Yoon Ki   Bae Jin Woo   Park Ki Dong  

Expert Opinion on Drug Delivery, Vol. 5, Iss. 11, 2008-11 ,pp. : 1173-1184

Informa Healthcare

Access to resources Recommend Favorite

Delivery approaches for angiogenic growth factors in the treatment of ischemic conditions

By Amsden Brian G  

Expert Opinion on Drug Delivery, Vol. 8, Iss. 7, 2011-07 ,pp. : 873-890

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular diseases, risk factors and short-term heart rate variability in an elderly general population: the CARLA study 2002–2006

By Greiser Karin   Kluttig Alexander   Schumann Barbara   Swenne Cees   Kors Jan   Kuss Oliver   Haerting Johannes   Schmidt Hendrik   Thiery Joachim   Werdan Karl  

European Journal of Epidemiology, Vol. 24, Iss. 3, 2009-03 ,pp. : 123-142

Springer Publishing Company

Access to resources Recommend Favorite

Chronopharmacology and controlled drug release

By Lemmer Björn  

Expert Opinion on Drug Delivery, Vol. 2, Iss. 4, 2005-07 ,pp. : 667-681

Informa Healthcare

Access to resources Recommend Favorite

Controlled-release microchips

By Sharma Sadhana   Nijdam A Jasper   Sinha Piyush M   Walczak Robbie J   Liu Xuewu   Cheng Mark M-C   Ferrari Mauro  

Expert Opinion on Drug Delivery, Vol. 3, Iss. 3, 2006-05 ,pp. : 379-394

Informa Healthcare

Access to resources Recommend Favorite